[1]
K. P. D. la C. Guanoliquin, D. C. S. Juca, Y. P. Alcocer, and S. P. A. Cuadrado, “Modulation of the gut-brain axis through selective inhibition of the sodium-glucose cotransporter type 1: physiological and therapeutic implications”, Int J Res Med Sci, vol. 14, no. 7, pp. 3009–3016, Jun. 2026.